Back to FDA Cybersecurity 101

    Premarket Cybersecurity Submission

    The bundle of cybersecurity artifacts a sponsor includes in a 510(k), De Novo, PMA, or HDE submission for a cyber device.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed September 19, 2026

    Definition

    A premarket cybersecurity submission is the formal collection of cybersecurity documentation - threat model, risk assessment, security architecture views, SBOM, vulnerability management plan, security testing results, and end-user labeling - that FDA requires under section 524B for any cyber device. The September 2023 FDA guidance "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions" describes the expected content in detail, replacing the 2014 and 2018 draft guidances.
    What the regulation says
    FDA expects the submission to demonstrate a Secure Product Development Framework (SPDF) - meaning cybersecurity is engineered in, not bolted on. Reviewers look for: a comprehensive STRIDE or similar threat model traceable to the device's intended use; a cybersecurity risk assessment integrated with ISO 14971 safety risk; security architecture views (global system, multi-patient harm, updateability/patchability, security use case); a CycloneDX or SPDX SBOM with vulnerability and end-of-support information; testing evidence (vulnerability scanning, penetration testing, fuzz testing, SAST/DAST); a coordinated vulnerability disclosure process; and labeling that informs operators about the device's security posture.

    What this means in practice

    The premarket package is the single largest cybersecurity deliverable a MedTech team produces. Most successful teams build it incrementally throughout development rather than at the end - threat model in design phase, SBOM from CI/CD, pen test before V&V freeze, labeling alongside the IFU. Late-stage scrambling to assemble the package is the leading cause of Refuse-to-Accept findings and Major Deficiency letters.

    Examples

    • A manufacturer developing a new infusion pump ensures its premarket cybersecurity submission includes a detailed threat model identifying potential risks like unauthorized access and data tampering.
    • For a novel diagnostic imaging system, the MedTech team generates a comprehensive Software Bill of Materials (SBOM) to be part of the premarket package, documenting all third-party components.
    • Before submitting a connected insulin delivery device, the sponsor conducts thorough penetration testing and includes the results and a vulnerability management plan in their premarket cybersecurity submission.
    Common pitfalls
    • •Building the cybersecurity package after V&V is frozen - gaps surface that require design changes.
    • •Submitting a threat model that lists only generic threats (e.g., 'malware') without device-specific attack paths.
    • •Treating penetration testing as a one-shot at submission instead of a recurring activity tied to design changes.
    • •Failing to integrate cybersecurity risk into the ISO 14971 risk management file - FDA expects one unified risk picture.

    Frequently asked questions

    The 2014 guidance (premarket) and 2016 guidance (postmarket) were short and high-level. The 2018 draft introduced Tier 1/Tier 2 device tiers. The September 2023 final guidance is the current authority - it consolidates premarket expectations and operationalizes the section 524B statutory requirements.

    Cross-references

    Uses

    Used by

    See also

    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Sources

    3 sources

    Every citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 1Binding law and standards· 1Tier 2Regulator guidance and consensus· 2
    Link health: 3 verified· last checked 2026-06-20
    FDA·2ISO/IEC·1
    1. 1
      Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions (Sept 2023)
      Tier 2 Verified
      FDAfda.gov
    2. 2
      FDA Digital Health Center of Excellence - Cybersecurity
      Tier 2 Verified
      FDAfda.gov
    3. 3
      IEC 81001-5-1: Health software - Security activities in the product life cycle
      Tier 1 Verified
      ISO/IECiso.org

    Inline markers like [1] jump to the matching reference above.